Rocket Doctor AI Inc. (AIRDF) — AI Hisse Senedi Analizi

Rocket Doctor AI Inc. provides personalized healthcare information services in Canada, utilizing a mobile application for symptom assessment and ongoing wellness management. The company operates in the healthcare information services sector, offering digital health solutions and medical education resources.

Şirket Genel Bakışı

ÇOK UZUN; OKUMADIM:

Rocket Doctor AI Inc., based in Canada, develops and offers a mobile application for personalized healthcare information and symptom assessment. The company provides digital health solutions and medical education resources, positioning itself within the competitive healthcare information services sector with a focus on mobile accessibility and user-centric design.

AIRDF Hakkında

Rocket Doctor AI Inc., formerly known as Treatment.com AI Inc., was incorporated in 2018 and is headquartered in Vancouver, Canada. The company focuses on delivering personalized healthcare information services through its mobile application. This application allows users to assess their symptoms, address health concerns, and manage their wellness. The company also offers a digital health app that provides insights into health management. Rocket Doctor AI Inc. provides medical education, medical clinic, and clinical advisor solutions, enhancing its service offerings. The company aims to provide accessible and personalized healthcare information resources to its users. The company rebranded in August 2025 to reflect its focus on AI-driven healthcare solutions. Rocket Doctor AI Inc. operates primarily in Canada, focusing on expanding its digital health services and mobile application reach within the region. The company's business model centers around providing accessible and personalized healthcare information through digital platforms.

Yatırım Tezi

Rocket Doctor AI Inc. presents an investment opportunity within the growing digital health information services sector. The company's focus on personalized healthcare through its mobile application and digital health tools aligns with the increasing demand for accessible and convenient healthcare solutions. With a market capitalization of $0.04 billion and a negative P/E ratio of -4.44, the company is currently operating at a loss, indicated by a profit margin of -1670.1%. However, the company's high gross margin of 89.4% suggests potential for profitability as it scales its operations. Key growth catalysts include expanding the user base of its mobile application and developing new digital health solutions. Investors should monitor the company's ability to achieve profitability and manage its operational costs effectively. The company's beta of -0.32 indicates low volatility compared to the market.

Sektör Bağlamı

Rocket Doctor AI Inc. operates in the healthcare information services sector, which is experiencing significant growth due to increasing demand for digital health solutions and personalized healthcare. The market is competitive, with players like BLOZF (BioLife Sciences Inc.), CRRVF (CareRx Corporation), DSOL (Data Solutions Holdings, Inc.), HBPCF (HBP Corp), and INNMF (InnoMedica Holdings AG). These companies offer various digital health services, including telehealth, remote patient monitoring, and healthcare data analytics. Rocket Doctor AI Inc. differentiates itself through its focus on AI-driven symptom assessment and personalized healthcare information delivered via its mobile application. The industry is driven by technological advancements, regulatory changes, and increasing healthcare costs, creating opportunities for innovative companies like Rocket Doctor AI Inc.

Medical - Healthcare Information Services

Healthcare

Büyüme Fırsatları

Expansion of Mobile Application User Base: Rocket Doctor AI Inc. can grow by expanding the user base of its mobile application. The global mobile health market is projected to reach $332.5 billion by 2028, growing at a CAGR of 17.9%. By focusing on user acquisition through targeted marketing and partnerships with healthcare providers, Rocket Doctor AI Inc. can increase its market share and revenue. Timeline: Ongoing.
Development of New Digital Health Solutions: The company can develop new digital health solutions to address unmet needs in the market. The digital health market is expected to reach $660 billion by 2027. By investing in research and development, Rocket Doctor AI Inc. can create innovative products and services that attract new customers and generate additional revenue streams. Timeline: Ongoing.
Partnerships with Healthcare Providers: Rocket Doctor AI Inc. can partner with healthcare providers to integrate its solutions into their existing workflows. The healthcare IT market is projected to reach $390.7 billion by 2027. By collaborating with hospitals, clinics, and other healthcare organizations, Rocket Doctor AI Inc. can expand its reach and improve patient outcomes. Timeline: Ongoing.
Geographic Expansion: The company can expand its operations beyond Canada to other countries with similar healthcare needs. The global healthcare market is projected to reach $10 trillion by 2022. By entering new markets, Rocket Doctor AI Inc. can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Within the next 3-5 years.
Integration of AI and Machine Learning: Rocket Doctor AI Inc. can further integrate AI and machine learning into its platform to enhance its capabilities. The AI in healthcare market is projected to reach $45.2 billion by 2026. By leveraging AI, the company can improve the accuracy of its symptom assessments, personalize its recommendations, and automate its processes. Timeline: Ongoing.

Market capitalization of $0.04 billion indicates a small-cap company with potential for growth.
Negative P/E ratio of -4.44 reflects current losses, but also potential for future earnings growth.
Gross margin of 89.4% demonstrates strong pricing power and efficient cost management.
Profit margin of -1670.1% highlights significant operational losses requiring strategic improvement.
Beta of -0.32 suggests the stock is less volatile than the overall market.

Ne Yaparlar

Develops a mobile application for symptom assessment.
Offers personalized healthcare information services.
Provides a digital health app for health insights.
Offers medical education solutions.
Provides medical clinic solutions.
Provides clinical advisor solutions.
Offers healthcare information resources.

İş Modeli

Generates revenue through subscriptions to its digital health app.
Partnerships with healthcare providers for integration of its solutions.
Offers medical education and clinical advisor solutions on a fee-for-service basis.

Individual users seeking personalized healthcare information.
Healthcare providers looking to integrate digital health solutions.
Medical professionals seeking medical education resources.

Proprietary AI-driven symptom assessment technology.
Established partnerships with healthcare providers.
First-mover advantage in the Canadian market for personalized healthcare information services.

Katalizörler

Upcoming: Expansion of mobile application user base through targeted marketing campaigns.
Ongoing: Development of new digital health solutions to address unmet needs in the market.
Ongoing: Partnerships with healthcare providers to integrate its solutions into their existing workflows.
Upcoming: Geographic expansion to other countries with similar healthcare needs.
Ongoing: Integration of AI and machine learning into its platform to enhance its capabilities.

Riskler

Potential: Competition from established healthcare information service providers with greater resources.
Potential: Regulatory changes in the healthcare industry that could impact the company's operations.
Ongoing: Data privacy and security concerns related to the collection and storage of patient data.
Potential: Technological obsolescence due to rapid advancements in digital health technologies.
Ongoing: Limited financial disclosure and liquidity associated with trading on the OTC Other tier.

Güçlü Yönler

Proprietary mobile application for symptom assessment.
Focus on personalized healthcare information.
Partnerships with healthcare providers.
High gross margin of 89.4%.

Zayıflıklar

Negative P/E ratio and profit margin indicate current losses.
Limited geographic presence in Canada.
Small market capitalization of $0.04 billion.
Reliance on mobile application for revenue generation.

Fırsatlar

Expansion of mobile application user base.
Development of new digital health solutions.
Geographic expansion to other countries.
Integration of AI and machine learning.

Tehditler

Competition from established healthcare information service providers.
Regulatory changes in the healthcare industry.
Data privacy and security concerns.
Technological obsolescence.

Rakipler & Benzerleri

BioLife Sciences Inc. — Focuses on biotechnology and life sciences, offering different healthcare solutions. — (BLOZF)
CareRx Corporation — Provides pharmacy services to seniors, a different segment of the healthcare market. — (CRRVF)
Data Solutions Holdings, Inc. — Offers data analytics solutions, which may overlap in healthcare data analysis. — (DSOL)
HBP Corp — Unknown differentiation due to lack of available data. — (HBPCF)
InnoMedica Holdings AG — Focuses on pharmaceutical development, a different aspect of healthcare. — (INNMF)

Key Metrics

Volume: 0
MoonshotScore: 56/100

Company Profile

CEO: Essam Hamza
Headquarters: Vancouver, CA
Founded: 2025

AI Insight

AI analysis pending for AIRDF

OTC Tier: OTC Other
Disclosure Status: Unknown

Sorular & Cevaplar

What does Rocket Doctor AI Inc. do?

Rocket Doctor AI Inc. is a Canadian company that provides personalized healthcare information services. It develops and offers a mobile application that allows users to assess their symptoms, address health concerns, and manage their wellness. The company also provides a digital health app for health insights, as well as medical education, medical clinic, and clinical advisor solutions. Rocket Doctor AI Inc. aims to provide accessible and personalized healthcare information resources through digital platforms, focusing on AI-driven symptom assessment and healthcare solutions.

What do analysts say about AIRDF stock?

As of March 17, 2026, there is no available analyst coverage or consensus for Rocket Doctor AI Inc. (AIRDF) due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-4.44) and profit margin (-1670.1%) indicate the company is currently unprofitable, while its gross margin of 89.4% suggests potential for future profitability. Investors should conduct their own due diligence and assess the company's growth prospects and risk factors before making any investment decisions.

What are the main risks for AIRDF?

The main risks for Rocket Doctor AI Inc. include competition from established healthcare information service providers, regulatory changes in the healthcare industry, and data privacy and security concerns. Additionally, the company faces the risk of technological obsolescence due to rapid advancements in digital health technologies. As an OTC-listed company, AIRDF also carries risks associated with limited financial disclosure, lower liquidity, and potential for price volatility. Investors should carefully consider these risks before investing in AIRDF.

Is AIRDF a good investment right now?

Use the AI score and analyst targets on this page to evaluate Rocket Doctor AI Inc. (AIRDF). Our analysis considers fundamentals, technicals, and market sentiment to help you decide.

What is the MoonshotScore for AIRDF?

The MoonshotScore is a proprietary 0-100 AI rating that evaluates Rocket Doctor AI Inc. across multiple dimensions including financial health, growth trajectory, and risk factors.

Where can I find AIRDF financial statements?

Rocket Doctor AI Inc. financial data including revenue, earnings, and balance sheet metrics are available in the Financials tab on this page, sourced from institutional-grade data providers.

What do analysts say about AIRDF?

Analyst consensus targets and ratings for Rocket Doctor AI Inc. are shown in the analysis section. These are aggregated from major Wall Street firms and updated regularly.

How volatile is AIRDF stock?

Check the beta and historical price range on this page to assess Rocket Doctor AI Inc.'s volatility relative to the broader market.